Literature DB >> 15608695

Quassinoids can induce mitochondrial membrane depolarisation and caspase 3 activation in human cells.

A Rosati, E Quaranta, M Ammirante, M C Turco, A Leone, V De Feo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15608695     DOI： 10.1038/sj.cdd.4401534

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN： 1350-9047            Impact factor:   15.828


× No keyword cloud information.
  14 in total

1.  Antitumor Agents. 282. 2'-(R)-O-acetylglaucarubinone, a quassinoid from Odyendyea gabonensis as a potential anti-breast and anti-ovarian cancer agent.

Authors:  Yoshihide Usami; Kyoko Nakagawa-Goto; Jing-Yu Lang; Yoon Kim; Chin-Yu Lai; Masuo Goto; Nobuko Sakurai; Masahiko Taniguchi; Toshiyuki Akiyama; Susan L Morris-Natschke; Kenneth F Bastow; Gordon Cragg; David J Newman; Mihoyo Fujitake; Koichi Takeya; Mien-Chie Hung; Eva Y-H P Lee; Kuo-Hsiung Lee
Journal:  J Nat Prod       Date:  2010-09-24       Impact factor: 4.050

2.  BAG3 protein is overexpressed in human glioblastoma and is a potential target for therapy.

Authors:  Michelina Festa; Luis Del Valle; Kamel Khalili; Renato Franco; Giosuè Scognamiglio; Vincenzo Graziano; Vincenzo De Laurenzi; Maria Caterina Turco; Alessandra Rosati
Journal:  Am J Pathol       Date:  2011-05-10       Impact factor: 4.307

3.  Antimalarial activity of simalikalactone E, a new quassinoid from Quassia amara L. (Simaroubaceae).

Authors:  N Cachet; F Hoakwie; S Bertani; G Bourdy; E Deharo; D Stien; E Houel; H Gornitzka; J Fillaux; S Chevalley; A Valentin; V Jullian
Journal:  Antimicrob Agents Chemother       Date:  2009-08-10       Impact factor: 5.191

4.  Antitumor activity of the Ailanthus altissima bark phytochemical ailanthone against breast cancer MCF-7 cells.

Authors:  Ruxing Wang; Yanjie Lu; Hong Li; Lixin Sun; Ning Yang; Mingzhen Zhao; Manli Zhang; Qingwen Shi
Journal:  Oncol Lett       Date:  2018-02-13       Impact factor: 2.967

5.  Quassinoid inhibition of AP-1 function does not correlate with cytotoxicity or protein synthesis inhibition.

Authors:  John A Beutler; Moon-Il Kang; Francis Robert; Jason A Clement; Jerry Pelletier; Nancy H Colburn; Tawnya C McKee; Ekaterina Goncharova; James B McMahon; Curtis J Henrich
Journal:  J Nat Prod       Date:  2009-03-27       Impact factor: 4.050

6.  Anti-proliferative activity of the quassinoid NBT-272 in childhood medulloblastoma cells.

Authors:  André O von Bueren; Tarek Shalaby; Julia Rajtarova; Duncan Stearns; Charles G Eberhart; Lawrence Helson; Alexandre Arcaro; Michael A Grotzer
Journal:  BMC Cancer       Date:  2007-01-25       Impact factor: 4.430

7.  A Microplate-Based Nonradioactive Protein Synthesis Assay: Application to TRAIL Sensitization by Protein Synthesis Inhibitors.

Authors:  Curtis J Henrich
Journal:  PLoS One       Date:  2016-10-21       Impact factor: 3.240

8.  Ailanthone Inhibits Huh7 Cancer Cell Growth via Cell Cycle Arrest and Apoptosis In Vitro and In Vivo.

Authors:  Zhenjian Zhuo; Jianyang Hu; Xiaolin Yang; Minfen Chen; Xueping Lei; Lijuan Deng; Nan Yao; Qunlong Peng; Zhesheng Chen; Wencai Ye; Dongmei Zhang
Journal:  Sci Rep       Date:  2015-11-03       Impact factor: 4.379

9.  Ailanthone targets p23 to overcome MDV3100 resistance in castration-resistant prostate cancer.

Authors:  Yundong He; Shihong Peng; Jinhua Wang; Huang Chen; Xiaonan Cong; Ang Chen; Meichun Hu; Min Qin; Haigang Wu; Shuman Gao; Liguo Wang; Xin Wang; Zhengfang Yi; Mingyao Liu
Journal:  Nat Commun       Date:  2016-12-13       Impact factor: 14.919

10.  A pharmacological screen for compounds that rescue the developmental lethality of a Drosophila ATM mutant.

Authors:  Stacey A Rimkus; David A Wassarman
Journal:  PLoS One       Date:  2018-01-16       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.